CME Group (CME) Upgraded to “Buy” at BidaskClub

BidaskClub upgraded shares of CME Group (NASDAQ:CME) from a hold rating to a buy rating in a research note released on Tuesday, BidAskClub reports.

A number of other research analysts also recently commented on the company. JPMorgan Chase & Co. initiated coverage on CME Group in a research note on Friday, February 15th. They issued an underweight rating and a $164.00 target price on the stock. Barclays lowered their target price on CME Group from $210.00 to $193.00 and set an overweight rating on the stock in a research note on Tuesday, March 26th. Deutsche Bank lowered their target price on CME Group from $220.00 to $214.00 and set a buy rating on the stock in a research note on Friday, March 15th. Sanford C. Bernstein restated an outperform rating and issued a $210.00 target price on shares of CME Group in a research note on Friday, February 15th. Finally, Citigroup set a $202.00 target price on CME Group and gave the company a buy rating in a research note on Thursday, May 2nd. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company’s stock. CME Group presently has a consensus rating of Hold and an average target price of $189.71.

Shares of CME stock traded up $1.69 on Tuesday, reaching $184.48. 14,535 shares of the company’s stock traded hands, compared to its average volume of 1,688,610. CME Group has a 12-month low of $157.21 and a 12-month high of $197.08. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.16. The company has a market capitalization of $65.59 billion, a price-to-earnings ratio of 26.88, a P/E/G ratio of 4.16 and a beta of 0.32.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.02. CME Group had a return on equity of 9.29% and a net margin of 42.47%. The business had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.19 billion. During the same quarter in the previous year, the company posted $1.86 earnings per share. CME Group’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, sell-side analysts predict that CME Group will post 6.62 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 10th will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Friday, June 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.63%. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

In other news, Director Ronald A. Pankau sold 200 shares of the company’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $182.90, for a total transaction of $36,580.00. Following the completion of the sale, the director now owns 3,600 shares in the company, valued at approximately $658,440. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Charles P. Carey sold 10,000 shares of the business’s stock in a transaction dated Wednesday, May 8th. The stock was sold at an average price of $179.02, for a total value of $1,790,200.00. Following the transaction, the director now directly owns 37,799 shares of the company’s stock, valued at approximately $6,766,776.98. The disclosure for this sale can be found here. In the last quarter, insiders have sold 38,489 shares of company stock valued at $6,739,196. 1.20% of the stock is currently owned by corporate insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of CME. Nordea Investment Management AB raised its holdings in shares of CME Group by 6.4% in the 3rd quarter. Nordea Investment Management AB now owns 125,008 shares of the financial services provider’s stock worth $21,281,000 after purchasing an additional 7,557 shares during the period. Morgan Stanley raised its holdings in shares of CME Group by 20.5% during the 3rd quarter. Morgan Stanley now owns 1,118,708 shares of the financial services provider’s stock valued at $190,415,000 after buying an additional 190,256 shares during the period. Marshall Wace LLP purchased a new stake in shares of CME Group during the 3rd quarter valued at about $990,000. First Hawaiian Bank raised its holdings in shares of CME Group by 25.1% during the 4th quarter. First Hawaiian Bank now owns 4,071 shares of the financial services provider’s stock valued at $766,000 after buying an additional 816 shares during the period. Finally, Contravisory Investment Management Inc. raised its holdings in shares of CME Group by 197.6% during the 4th quarter. Contravisory Investment Management Inc. now owns 253 shares of the financial services provider’s stock valued at $48,000 after buying an additional 168 shares during the period. 84.78% of the stock is owned by institutional investors and hedge funds.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: Calculating net profit and net profit margin ratio

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.